News Daily News Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist Todd Neale January 15, 2025
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News ACC 2024 IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease Caitlin E. Cox April 10, 2024
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022
News Daily News Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy Michael O'Riordan February 26, 2021
News Conference News VIVA 2020 DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD L.A. McKeown November 09, 2020
News Opinion Editor's Corner TCT 2020 TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More Shelley Wood October 09, 2020
News Daily News Endovascular Stroke Therapy Less Beneficial After Transfer Caitlin E. Cox August 27, 2020
News Daily News Skipping tPA Before Stroke Thrombectomy May Be Okay: DIRECT-MT Todd Neale May 11, 2020
News Conference News ISC 2020 Stroke Thrombectomy for Basilar Artery Occlusions Gains Support: Registry Todd Neale February 25, 2020
News Daily News DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms Caitlin E. Cox July 11, 2019
News Conference News ISC 2019 MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results Todd Neale February 08, 2019
News Daily News Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies L.A. McKeown January 23, 2019
News Industry News New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment January 29, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017